Ovid Therapeutics EPS Diluted from Accounting Change (Quarterly) Insights

Ovid Therapeutics, Inc. (OVID)

1.61 -0.04 (-2.42%) USD | NASDAQ | Feb 27, 14:18

View EPS Diluted from Accounting Change (Quarterly) for OVID.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Accounting Change (Quarterly) Benchmarks

Start Trial

Cassava Sciences, Inc.	--
PTC Therapeutics, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--